Name: Latest research reports of Biocon Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Biocon Ltd.
Rating: 5
Author: ICICI Securities Limited

Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer

399.0000 4.50 (1.14%)

NSE Dec 02, 2025 15:31 PM

37.11% Gain from 52W Low

Volume: 2.9M

Biocon Ltd.

26 Oct 2018

399.00

1.14%

Biocon

Buy: Biocon Ltd.

ICICI Securities Limited

ICICI Securities Ltd | Retail Equity Research Strong Q2 numbers were on the back of 136% YoY growth in Biologics segment led by commercial launch of biosimilar...

Axis Direct decreased Buy price target of Biocon Ltd. to 440.0 on 01 Dec, 2025.